“…This assumption is based on structural analysis, for example of CS-D (38,42,43), and on the immunohistological analysis of mAbs generated against chondroitin sulfates (44,45,71,72). These different mAbs yielded distinct spatial and temporal staining profiles in developing and in lesioned neural tissues (39,40,46). One further example is provided by the neurite outgrowth-promoting DSD-1 epitope, which is expressed in regions of intense axon growth in vivo, e.g.…”